The FDA approved Mallinckrodt Pharmaceuticals’ Terlivaz (terlipressin) in adults with hepatorenal syndrome (HRS), making it the only FDA-approved drug for that indication in the U.S.
https://www.pharmalive.com/wp-content/uploads/2016/08/biospace-news-815x450-mallinckrot.jpg450815BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2022-09-16 12:10:192022-09-16 12:10:19Mallinckrodt’s Terlivaz becomes first FDA-approved drug for hepatorenal syndrome